The selling seems to be clue'less retail investors who did NOT read the report, or who have stops getting hit. If you READ the REPORT, you'll find solid statistically significant positive results in LDL, HDL, weight loss, and safety. The only disappointment is that this report ALONE will not meet the FDA criteria. If anyone has any other negative news, please point it out. I've read the report and find no justification for the stock trading at 3.9. There are more study results to come out mid year. Until then, I expect the stock will trade in the 5.7-6 area based on fair value. Buy panics, don't sell them. Again, read the report. Also note all the 10%+ owners who purchased large blocks AFTER the resignation a month ago. They perhaps knew the good results form the drug. Yeah, it didn't quite meet the 5% criterion, but it's close, and there's more studies. don't listen to the adolescents on this board.